TGFB1 and neoplasm: In preclinical solid tumor models, CAR T cells with TGF-β resistance showed significantly better tumor infiltration, sustained proliferation within the tumor microenvironment, and enhanced cytotoxic activity against target cells, while avoiding the T-cell dysfunction usually caused by chronic TGF-β exposure [166,170].